These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Epithelial Aryl Hydrocarbon Receptor Protects From Mucus Production by Inhibiting ROS-Triggered NLRP3 Inflammasome in Asthma. Hu X; Shen Y; Zhao Y; Wang J; Zhang X; Tu W; Kaufman W; Feng J; Gao P Front Immunol; 2021; 12():767508. PubMed ID: 34868022 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation. Primiano MJ; Lefker BA; Bowman MR; Bree AG; Hubeau C; Bonin PD; Mangan M; Dower K; Monks BG; Cushing L; Wang S; Guzova J; Jiao A; Lin LL; Latz E; Hepworth D; Hall JP J Immunol; 2016 Sep; 197(6):2421-33. PubMed ID: 27521339 [TBL] [Abstract][Full Text] [Related]
7. The NLRP3 inflammasome modulates glycolysis by increasing PFKFB3 in an IL-1β-dependent manner in macrophages. Finucane OM; Sugrue J; Rubio-Araiz A; Guillot-Sestier MV; Lynch MA Sci Rep; 2019 Mar; 9(1):4034. PubMed ID: 30858427 [TBL] [Abstract][Full Text] [Related]
8. Jinxin oral liquid inhibits human respiratory syncytial virus-induced excessive inflammation associated with blockade of the NLRP3/ASC/Caspase-1 pathway. Shen C; Zhang Z; Xie T; Xu J; Yan J; Kang A; Dai Q; Wang S; Ji J; Shan J Biomed Pharmacother; 2018 Jul; 103():1376-1383. PubMed ID: 29864921 [TBL] [Abstract][Full Text] [Related]
9. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317 [TBL] [Abstract][Full Text] [Related]
10. Nlrp3 Inflammasome Inhibitor MCC950 Ameliorates Obliterative Bronchiolitis by Inhibiting Th1/Th17 Response and Promoting Treg Response After Orthotopic Tracheal Transplantation in Mice. Xu KY; Tong S; Wu CY; Ding XC; Chen JL; Ming Y; Wang SH Transplantation; 2020 Jun; 104(6):e151-e163. PubMed ID: 32108749 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death. Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823 [TBL] [Abstract][Full Text] [Related]
13. MCC950/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition. Vande Walle L; Stowe IB; Šácha P; Lee BL; Demon D; Fossoul A; Van Hauwermeiren F; Saavedra PHV; Šimon P; Šubrt V; Kostka L; Stivala CE; Pham VC; Staben ST; Yamazoe S; Konvalinka J; Kayagaki N; Lamkanfi M PLoS Biol; 2019 Sep; 17(9):e3000354. PubMed ID: 31525186 [TBL] [Abstract][Full Text] [Related]
14. Conditioned medium from persistently RSV-infected macrophages alters transcriptional profile and inflammatory response of non-infected macrophages. Rivera-Toledo E; Salido-Guadarrama I; Rodríguez-Dorantes M; Torres-González L; Santiago-Olivares C; Gómez B Virus Res; 2017 Feb; 230():29-37. PubMed ID: 28069520 [TBL] [Abstract][Full Text] [Related]
15. Blockage of NLRP3 inflammasome activation ameliorates acute inflammatory injury and long-term cognitive impairment induced by necrotizing enterocolitis in mice. Zhu F; Wang L; Gong Z; Wang Y; Gao Y; Cai W; Wu J J Neuroinflammation; 2021 Mar; 18(1):66. PubMed ID: 33676524 [TBL] [Abstract][Full Text] [Related]
16. The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. Qu J; Yuan Z; Wang G; Wang X; Li K Int Immunopharmacol; 2019 May; 70():147-155. PubMed ID: 30802677 [TBL] [Abstract][Full Text] [Related]
17. FSTL1 aggravates OVA-induced inflammatory responses by activating the NLRP3/IL-1β signaling pathway in mice and macrophages. Wang Y; Zhang D; Liu T; Wang JF; Wu JX; Zhao JP; Xu JW; Zhang JT; Dong L Inflamm Res; 2021 Jul; 70(7):777-787. PubMed ID: 34076707 [TBL] [Abstract][Full Text] [Related]
18. IL-13-induced airway hyperreactivity during respiratory syncytial virus infection is STAT6 dependent. Tekkanat KK; Maassab HF; Cho DS; Lai JJ; John A; Berlin A; Kaplan MH; Lukacs NW J Immunol; 2001 Mar; 166(5):3542-8. PubMed ID: 11207314 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. Dolunay A; Senol SP; Temiz-Resitoglu M; Guden DS; Sari AN; Sahan-Firat S; Tunctan B Inflammation; 2017 Apr; 40(2):366-386. PubMed ID: 27924425 [TBL] [Abstract][Full Text] [Related]
20. NLRP3 inflammasome inhibition attenuates subacute neurotoxicity induced by acrylamide in vitro and in vivo. Sui X; Yang J; Zhang G; Yuan X; Li W; Long J; Luo Y; Li Y; Wang Y Toxicology; 2020 Feb; 432():152392. PubMed ID: 32014472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]